About
Pairidex develops FusionMRD™, a droplet digital PCR assay for sensitive and accurate detection of gene fusions in blood cancers to monitor treatment response and disease progression.
Explore Pairidex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.